Rahul Kodgule

908 total citations
33 papers, 610 citations indexed

About

Rahul Kodgule is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Signal Processing. According to data from OpenAlex, Rahul Kodgule has authored 33 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 4 papers in Signal Processing. Recurrent topics in Rahul Kodgule's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (10 papers) and Phonocardiography and Auscultation Techniques (6 papers). Rahul Kodgule is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (10 papers) and Phonocardiography and Auscultation Techniques (6 papers). Rahul Kodgule collaborates with scholars based in India, United States and United Kingdom. Rahul Kodgule's co-authors include Sundeep Salvi, Daniel Chamberlain, R. Fletcher, Stephen J. Smith, Adrian L. Lopresti, Vivek Miglani, Bill Brashier, Sapna Madas, Jaideep Gogtay and Monika Tandon and has published in prestigious journals such as Diabetes, European Respiratory Journal and Drugs.

In The Last Decade

Rahul Kodgule

31 papers receiving 587 citations

Peers

Countries citing papers authored by Rahul Kodgule

Since Specialization

Citations

This map shows the geographic impact of Rahul Kodgule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul Kodgule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul Kodgule more than expected).

Fields of papers citing papers by Rahul Kodgule

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul Kodgule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul Kodgule. The network helps show where Rahul Kodgule may publish in the future.

Co-authorship network of co-authors of Rahul Kodgule

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul Kodgule. A scholar is included among the top collaborators of Rahul Kodgule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul Kodgule. Rahul Kodgule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of a Combination of Remogliflozin Etabonate and Vildagliptin as Fixed Doses in Patients with Type-2 Diabetes Mellitus: A Randomized, Active-Controlled, Double-Blind Study. (FOREVER STUDY) 2024 ·Paramesh Shamanna, (unknown), Brij Mohan, (unknown), Arumugam Balamurugan, Manoj Chawla, Arthur Asirvatham, (unknown), Sandeep K. Gupta, (unknown), Rahul Kodgule, Monika Tandon, Amol Pendse, (unknown), (unknown), (unknown)	2
2	A Randomized, Double-blind, Active-controlled Study of Remogliflozin Etabonate 100 mg plus Teneligliptin 10 mg Twice-daily versus Teneligliptin 20 mg Oncedaily as add-on to Metformin Monotherapy in Indian Diabetic Patients 2022 ·Rahul Kodgule, Monika Tandon, (unknown), Amol Pendse, (unknown), M. Kumar, (unknown), (unknown), Hanmant Barkate, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial 2022 ·The Lancet Regional Health - Southeast Asia ·Monika Tandon, (unknown), Keith Moore, Stephen Winchester, Yuan-Po Tu, (unknown), Rahul Kodgule, Amol Pendse, (unknown), Shashank Joshi	23
4	Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial 2021 ·ERJ Open Research ·Sundeep Salvi, (unknown), Srikanth V. Krishnamurthy, (unknown), Saiprasad Patil, Rahul Kodgule, (unknown), Amol Pendse, (unknown), (unknown), Monika Tandon, Hanmant Barkate	6
5	Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial 2020 ·Drugs ·Mala Dharmalingam, S. R. Aravind, Hemant Thacker, Paramesh Shamanna, Brij Mohan, Manoj Chawla, Arthur Asirvatham, Ramesh K. Goyal, (unknown), Balamurugan Ramadass, (unknown), (unknown), Rahul Kodgule, Monika Tandon, Sivakumar Vaidyanathan, Amol Pendse, (unknown), (unknown), (unknown), Hanmant Barkate	41
6	An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract 2019 ·Murdoch Research Repository (Murdoch University) ·Adrian L. Lopresti, Stephen J. Smith, (unknown), Rahul Kodgule	2
7	An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract 2019 ·Medicine ·Adrian L. Lopresti, Stephen J. Smith, (unknown), Rahul Kodgule	133
8	X5 values measured on Impulse Oscillometry (IOS) help differentiate healthy, asthmatic, COPD and ILD subjects from one another. 2018 ·(unknown), (unknown), (unknown), (unknown), Sapna Madas, Rahul Kodgule, Sundeep Salvi, Shrikant Pawar	2
9	Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study 2017 ·npj Primary Care Respiratory Medicine ·(unknown), Sundeep Salvi, Rahul Kodgule	46
10	Use of spirometry among chest physicians and primary care physicians in India 2016 ·npj Primary Care Respiratory Medicine ·(unknown), (unknown), Sapna Madas, Rahul Kodgule, Jaideep Gogtay, Sundeep Salvi	24
11	A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation 2016 ·Lung India ·Sundeep Salvi, (unknown), Rahul Kodgule, Jaideep Gogtay	3
12	Mobile stethoscope and signal processing algorithms for pulmonary screening and diagnostics 2015 ·Daniel Chamberlain, (unknown), R. Fletcher, Rahul Kodgule	20
13	Evaluation of peak flow meter for detecting airflow limitation and predicting clinical diagnosis 2014 ·European Respiratory Journal ·(unknown), (unknown), Sundeep Salvi, Rahul Kodgule, (unknown)	0
14	Evaluation of COPD-6 device for detecting airflow limitation and predicting clinical diagnosis 2014 ·European Respiratory Journal ·(unknown), (unknown), Sundeep Salvi, Rahul Kodgule, (unknown)	1
15	Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects 2014 ·European Respiratory Journal ·(unknown), (unknown), (unknown), (unknown), Tavpritesh Sethi, Anurag Agrawal, Sundeep Salvi, Rahul Kodgule, Bill Brashier	1
16	Reference values for peak expiratory flow in Indian adult population using a European Union scale peak flow meter 2014 ·Journal of Postgraduate Medicine ·Rahul Kodgule, (unknown), Raja Dhar, (unknown), Sapna Madas, (unknown), (unknown), Parvaiz A Koul	18
17	Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200 mg/day NAC in moderate to severe COPD patients: A pilot study 2013 ·Respiratory Physiology & Neurobiology ·(unknown), (unknown), Rahul Kodgule, (unknown), Sapna Madas, (unknown), Sundeep Salvi, Bill Brashier	10
18	Correlation of spirometry with impulse oscillometry, body plethysmography and DLCO 2013 ·European Respiratory Journal ·Rahul Kodgule, (unknown), (unknown), (unknown), (unknown), Sundeep Salvi	1
19	High resolution CT scan (HRCT) thorax differences between biomass-smoke exposure induced COPD (BM COPD) and tobacco-smoking COPD (TS COPD) 2012 ·Bill Brashier, (unknown), (unknown), Rahul Kodgule, (unknown), (unknown), Sapna Madas, Peter J. Barnes, Sundeep Salvi	3
20	Exposure to biomass smoke as a cause for airway disease in women and children 2011 ·Current Opinion in Allergy and Clinical Immunology ·Rahul Kodgule, Sundeep Salvi	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact